(tested or 100% immunogen sequence identity)
- Western blot (0.1 - 0.3 µg/ml)
- Peptide Enzyme-Linked Immunosorbent Assay (1:32000) & (0.1 - 0.3 µg/ml)
U2AF1L4 antibody was raised against synthetic peptide C-EDGERAVAELSNR from an internal region of human U2AF1L4 (NP_001035515.1 ; NP_659424.2). Percent identity with other species by BLAST analysis: Human (100%), Gibbon (92%), Mouse (85%), Rat (85%), Panda (85%), Dog (85%), Horse (85%), Rabbit (85%), Pig (85%).
- Lyophilized - 100 µg - $145.00
Immunizing peptide used to generate LS-C87227. Useful for pre-absorption and neutralization of the antibody's antigen binding site.
Human U2AF1L4. This antibody is expected to recognise both reported isoforms (NP_001035515.1 and NP_659424.2). No cross-reactivity with U2AF1 expected.
Peptide ELISA: antibody detection limit dilution 1:32000. Western Blot: Approx. 20Da band observed in Human Brain (Cerebellum) and Lung lysates (calculated MW of 21.3kD according to NP_001035515.1). Recommended concentration: 0.1-0.3 ug/ml.
Tris-buffered saline, pH 7.3, 0.5% BSA, 0.02% sodium azide
Store at -20°C. Avoid freeze-thaw cycles.
For research use only.
This antibody carries the LSBio 100% Guarantee.